• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Real-World Evidence

Our RWE team unites strong medical knowledge and customized solutions to deliver advanced clinical research

The world of clinical research is changing rapidly, and we are adapting to it to answer health product and care questions optimally. To achieve this, ZEG Berlin relies on three pillars essential to the success of Real-World Evidence projects:

Methodology

Standard approaches are no longer enough. Every research question is different, every study unique. Our mission is to answer your questions with customized solutions and employ the most advanced methods.

Data

The focus has shifted from data collection to interpreting and translating Real-World Evidence. We assist you in identifying, analyzing, and evaluating sophisticated data sources to provide stakeholders with meaningful decision-support schemes.

Medical Expertise

Our team is highly experienced and internationally known for its high-level research.


50+ non-interventional, retrospective, secondary data studies in the last three years

40+ Publications and posters

 

Disease area focus:

  • Oncology (e.g. Urothelial Cancer, Gastric Cancer, Prostate Cancer, MCL, CLL, NSCLC, Ovarian Cancer, RCC)
  • Metabolic Diseases (T1DM, T2DM)
  • Dermatology (Psoriasis, Prurigo Nodularis)
  • Osteoarthritis,
  • Vaccination (HCV, FSME)
  • Rare Diseases (Fabry Disease, Wilson disease, CAD)
  • Inflammatory Diseases (SLE, PsA, RA)
  • Cardiovascular Diseases
  • Allergy (Allergic asthma, Allergic rhinitis, CMPA)
  • Respiratory Diseases (COPD, Asthma)
  • Spasticity
  • Autoimmune Diseases (Crohn’s Disease, UC)
  • Nephrology (CKD, Hyperkalemia)
  • and many more
 

Find out more about our RWE Services

See our publication list RWE Publications

sidebar

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.